Crestone presents at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal. Oral Session: Discovery of CRS0393, a Potent MmpL3 Inhibitor as a Novel Antimycobacterial Agent.

Presentation
ECCMID 2022
Lisbon, Portugal
April 26, 2022
Topics: CRS0393 NTM/TB